Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels.

Journal of viral hepatitis - 1 Oct 2009

Iwasa M, Hara N, Miyachi H, Tanaka H, Takeo M, Fujita N, Kobayashi Y, Kojima Y, Kaito M, Takei Y

Abstract excerpt

Retinol-binding protein 4 (RBP4) is a recently identified adipokine that is elevated in the blood in several insulin-resistant states. We investigated the association between plasma RBP4 and histological and biochemical characteristics of chronic hepatitis C (CHC), as well as changes in RBP4 levels following interferon therapy. Eighty-one patients with CHC infected with genotype 1 received treatment with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatty Liver
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Liver Cirrhosis

Share to Plasma

Share to Polyethylene Glycols

Share to Retinol-Binding Proteins, Plasma

Share to Ribavirin

Source

Identifiers

PMID: 19302338
DOI: 10.1111/j.1365-2893.2009.01119.x

Genes

RBP4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels.PMID 19302338Read ↗

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.Semantic proximity Read ↗

Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C.Semantic proximity Read ↗

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.Semantic proximity Read ↗

Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy.Semantic proximity Read ↗

Unraveling the Lack of Correlation between RBP4 and MASLD: Insights from Gene Expression and Serum Level AnalysisSemantic proximity Read ↗

Serum lipids and chronic hepatitis C genotype 4: interaction and significance.Semantic proximity Read ↗

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.Semantic proximity Read ↗

Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.Semantic proximity Read ↗

Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.Semantic proximity Read ↗

Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study.Semantic proximity Read ↗

Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients.Semantic proximity Read ↗

Study of prevalence and effects of insulin resistance in patients with chronic hepatitis C genotype 4.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.